Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC
PHASE4CompletedINTERVENTIONAL
Enrollment
492
Participants
Timeline
Start Date
January 31, 2005
Primary Completion Date
July 31, 2010
Study Completion Date
July 31, 2010
Conditions
Leukemia, Nonlymphocytic, Acute
Interventions
DRUG
randomization between two established Chemotherapies
Trial Locations (1)
D-1307
Universitätsklinikum, Dresden
All Listed Sponsors
lead
Technische Universität Dresden
OTHER
NCT00180167 - Therapy of Acute Myeloid Leukemia in Patients Over the Age of 60 : DA Versus Mitoxantrone With Intermittent AraC | Biotech Hunter | Biotech Hunter